
Arthur Wong
business executiveMale0.0Global Dominance: 0.00%
Arthur Wong is the managing director for US health care practice at S&P Global. He has expressed concerns that the tariffs on pharmaceutical imports could ultimately burden consumers and patients, as the increased costs may lead to higher prices and limited availability of generic medications.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Arthur Wong, managing director for US health care practice at S&P Global, stated that the pain will ultimately be borne by the consumer.
New US tariffs could make it harder to get certain generic drugsCNN·
United States· 2025-04-16





